Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell P Dombrowski

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
American Journal of Obstetrics and Gynecology|September 15, 2005
Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm deliveryBaha Sibai, Paul J Meis, Mark Klebanoff, et al.
The New England Journal of Medicine|June 13, 2003
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproatePaul J Meis, Mark Klebanoff, Elizabeth Thom, et al.
American Journal of Obstetrics and Gynecology|September 15, 2005
Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous deliveryCatherine Y Spong, Paul J Meis, Elizabeth A Thom, et al.
American Journal of Obstetrics and Gynecology|August 12, 2020
Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm PreeclampsiaMichael J Paidas, Allan T N Tita, George A Macones, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
American Journal of Obstetrics and Gynecology|September 15, 2005
Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm deliveryBaha Sibai, Paul J Meis, Mark Klebanoff, et al.
The New England Journal of Medicine|June 13, 2003
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproatePaul J Meis, Mark Klebanoff, Elizabeth Thom, et al.
American Journal of Obstetrics and Gynecology|September 15, 2005
Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous deliveryCatherine Y Spong, Paul J Meis, Elizabeth A Thom, et al.
American Journal of Obstetrics and Gynecology|August 12, 2020
Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm PreeclampsiaMichael J Paidas, Allan T N Tita, George A Macones, et al.
Pageof 4